(19)
(11) EP 2 436 680 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A2)

(48) Corrigendum issued on:
23.05.2012 Bulletin 2012/21

(43) Date of publication:
04.04.2012 Bulletin 2012/14

(21) Application number: 11180383.9

(22) Date of filing: 21.09.2005
(51) International Patent Classification (IPC): 
C07D 311/58(2006.01)
A61P 35/00(2006.01)
A61K 31/353(2006.01)
A23L 1/30(2006.01)
 A61K 31/352(2006.01)
A23L 2/58(2006.01)
C07D 311/38(2006.01)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 21.09.2004 US 611299 P
29.10.2004 JP 2004315009
05.11.2004 AU 2004906363
03.05.2005 AU 2005201855
03.05.2005 US 676934 P
19.11.2004 WO PCT/AU2004/001619

(62) Application number of the earlier application in accordance with Art. 76 EPC:
05787045.3 / 1809618

(71) Applicant: Marshall Edwards, Inc.
San Diego, CA 92130 (US)

(72) Inventors:
  • Heaton, Andrew
    Sydney, New South Wales 2113 (AU)
  • Husband, Alan James
    Sydney, New South Wales 2113 (AU)

(74) Representative: Huenges, Martin 
Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3
80335 München
80335 München (DE)

 
Remarks:
This application was filed on 07-09-2011 as a divisional application to the application mentioned under INID code 62.
Remarks:
Claims filed after the date of receipt of the divisional application (Rule 68(4) EPC).
 


(54) Chroman derivatives, medicaments and use in therapy


(57) Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.